Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstract 2001
31 2-3 p. 353-
1 p.
artikel
2 A case-control study of lung cancer among Czech women Kubı́k, Antonı́n
2001
31 2-3 p. 111-122
12 p.
artikel
3 Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients Gridelli, Cesare
2001
31 2-3 p. 277-284
8 p.
artikel
4 Adenovirus expressing p27Kip1 induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts Park, Kyung-Ho
2001
31 2-3 p. 149-155
7 p.
artikel
5 Alteration of cell growth and morphology by overexpression of transforming growth factor β type II receptor in human lung adenocarcinoma cells Kim, Tae-Kyun
2001
31 2-3 p. 181-191
11 p.
artikel
6 A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC) Saito, Junichi
2001
31 2-3 p. 285-293
9 p.
artikel
7 Benign solitary fibrous tumor of the parietal pleura which invaded the intercostal muscle Nonaka, Makoto
2001
31 2-3 p. 325-329
5 p.
artikel
8 Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung Epaulard, Olivier
2001
31 2-3 p. 331-334
4 p.
artikel
9 Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine De Pas, Tommaso
2001
31 2-3 p. 267-270
4 p.
artikel
10 Comment on Katsimbri et al.: endobronchial metastases secondary to solid tumours, Lung Cancer Debeljak, A.
2001
31 2-3 p. 351-352
2 p.
artikel
11 Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients Pujol, Jean-Louis
2001
31 2-3 p. 221-231
11 p.
artikel
12 Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15 Cortesi, E.
2001
31 2-3 p. 271-276
6 p.
artikel
13 Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis Khuder, Sadik A.
2001
31 2-3 p. 139-148
10 p.
artikel
14 Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor Toyoshima, Eri
2001
31 2-3 p. 193-202
10 p.
artikel
15 Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980–1994 Remiszewski, P.
2001
31 2-3 p. 101-110
10 p.
artikel
16 Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B Kindler, Hedy L.
2001
31 2-3 p. 311-317
7 p.
artikel
17 Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer Biroš, Erik
2001
31 2-3 p. 157-162
6 p.
artikel
18 Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis Ueno, Kiyonobu
2001
31 2-3 p. 213-219
7 p.
artikel
19 Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations Potti, Anil
2001
31 2-3 p. 319-323
5 p.
artikel
20 Loss of p16 and/or pRb protein expression in NSCLC Chen, Jung-Ta
2001
31 2-3 p. 163-170
8 p.
artikel
21 Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994 Mannino, David M.
2001
31 2-3 p. 91-99
9 p.
artikel
22 Male lung cancer patients die earlier in life Austria 1976–1996 Groman, Ernest
2001
31 2-3 p. 335-337
3 p.
artikel
23 Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations Field, J.K.
2001
31 2-3 p. 339-345
7 p.
artikel
24 Ninth International Conference on Lung Cancer 2001
31 2-3 p. 355-359
5 p.
artikel
25 Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion Castagneto, Bruno
2001
31 2-3 p. 303-310
8 p.
artikel
26 Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer Ratanatharathorn, Vorachai
2001
31 2-3 p. 257-265
9 p.
artikel
27 Phase I study of paclitaxel (Taxol®) plus vinorelbine (Navelbine®) in patients with untreated stage IIIb and IV non-small cell lung cancer Breton, J.L.
2001
31 2-3 p. 295-301
7 p.
artikel
28 Primary lung sarcomas: long survivors obtained with iterative complete surgery Magné, Nicolas
2001
31 2-3 p. 241-245
5 p.
artikel
29 Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells Casibang, Marchessini
2001
31 2-3 p. 203-212
10 p.
artikel
30 Quality of life in lung cancer patients Montazeri, Ali
2001
31 2-3 p. 233-240
8 p.
artikel
31 Reversible hepatic coma possibly induced by docetaxel treatment Chen, Yuh-Min
2001
31 2-3 p. 347-348
2 p.
artikel
32 The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT) Freyer, Gilles
2001
31 2-3 p. 247-256
10 p.
artikel
33 Time for a global strategy to improve the treatment of lung cancer? Stephens, Richard
2001
31 2-3 p. 349-
1 p.
artikel
34 Tissue factor is the only activator of coagulation in cultured human lung cancer cells Keller, Thorsten
2001
31 2-3 p. 171-179
9 p.
artikel
35 Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe Janssen-Heijnen, Maryska L.G.
2001
31 2-3 p. 123-137
15 p.
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland